268 related articles for article (PubMed ID: 3023426)
41. Anomalous growth hormone response to vasoactive intestinal peptide and peptide histidine methionine in patients with prolactinoma or hypothalamic hyperprolactinemia.
Watanobe H; Tamura T; Takahashi K
Neuropeptides; 1994 Aug; 27(2):137-42. PubMed ID: 7991068
[TBL] [Abstract][Full Text] [Related]
42. Multiple endocrine neoplasia, type 1, with pancreatic cholera.
Namihira Y; Achord JL; Subramony C
Am J Gastroenterol; 1987 Aug; 82(8):794-7. PubMed ID: 2886044
[TBL] [Abstract][Full Text] [Related]
43. Clinical and hormonal aspects of the watery diarrhea-hypokalemia-achlorhydria (WDHA) syndrome due to vasoactive intestinal polypeptide (VIP)-producing tumor.
Yamaguchi K; Abe K; Adachi I; Tanaka M; Ueda M; Oka Y; Miyakawa S; Kameya T; Yanaihara N
Endocrinol Jpn; 1980 Dec; 27 Suppl 1():79-86. PubMed ID: 7014208
[TBL] [Abstract][Full Text] [Related]
44. WDHA (watery diarrhea, hypokalemia, achlorhydria) syndrome: clinical features, diagnosis, and treatment.
Grier JF
South Med J; 1995 Jan; 88(1):22-4. PubMed ID: 7817223
[TBL] [Abstract][Full Text] [Related]
45. Peptide histidine isoleucine- and vasoactive intestinal polypeptide-like immunoreactivity coexist in rat hypophysial portal blood.
Shimatsu A; Kato Y; Inoue T; Christofides ND; Bloom SR; Imura H
Neurosci Lett; 1983 Dec; 43(2-3):259-62. PubMed ID: 6689501
[TBL] [Abstract][Full Text] [Related]
46. A further study on the stimulatory effect of peptide histidine methionine on growth hormone secretion in acromegaly: a dose-related study and a comparison with vasoactive intestinal peptide.
Watanobe H; Takebe K
Neuropeptides; 1992 Oct; 23(2):115-9. PubMed ID: 1333573
[TBL] [Abstract][Full Text] [Related]
47. Characterization of a novel prepro VIP derived peptide.
Yiangou Y; Requejo F; Polak JM; Bloom SR
Biochem Biophys Res Commun; 1986 Sep; 139(3):1142-9. PubMed ID: 3767995
[TBL] [Abstract][Full Text] [Related]
48. Paradoxical response of growth hormone to peptide histidine methionine in acromegaly: comparison with the effects of thyrotropin-releasing hormone and vasoactive intestinal peptide.
Watanobe H; Sasaki S; Sone K; Takebe K
J Clin Endocrinol Metab; 1991 May; 72(5):982-5. PubMed ID: 1902488
[TBL] [Abstract][Full Text] [Related]
49. Characterization of an alpha-amidating activity in a human pancreatic tumour secreting vasoactive intestinal peptide (VIP).
Maltèse JY; Monge G; Giraud P; Salers P; Ouafik LH; Pelen F; Oliver C
Clin Endocrinol (Oxf); 1990 Oct; 33(4):467-80. PubMed ID: 2171816
[TBL] [Abstract][Full Text] [Related]
50. Vasoactive intestinal polypeptide and gastrin-producing islet cell carcinoma.
Judge DM; Demers LM; Nahrwold DL; Dickman PS; Petrokubi RJ; Trapukdi S
Arch Pathol Lab Med; 1977 May; 101(5):262-5. PubMed ID: 192171
[TBL] [Abstract][Full Text] [Related]
51. Production of VIP- and PHM (human PHI)-related peptides in human neuroblastoma cells.
Hoshino M; Yanaihara C; Ogino K; Iguchi K; Sato H; Suzuki T; Yanaihara N
Peptides; 1984; 5(2):155-60. PubMed ID: 6548020
[TBL] [Abstract][Full Text] [Related]
52. Location of PHM/VIP mRNA in human gastrointestinal tract detected by in situ hybridization.
Bredkjaer HE; Wulff BS; Emson PC; Fahrenkrug J
Cell Tissue Res; 1994 May; 276(2):229-38. PubMed ID: 8020060
[TBL] [Abstract][Full Text] [Related]
53. Chronic diarrhea of infancy: nonbeta islet cell hyperplasia.
Ghishan FK; Soper RT; Nassif ED; Younoszai MK
Pediatrics; 1979 Jul; 64(1):46-9. PubMed ID: 221877
[TBL] [Abstract][Full Text] [Related]
54. Peptide histidine methionine (PHM) increases ileostomy output.
Calam J; Yiangou Y; Chrysanthou B; Paul G; Mehta A; Bloom SR
Regul Pept; 1988 Oct; 23(1):57-62. PubMed ID: 3238051
[TBL] [Abstract][Full Text] [Related]
55. Clinicopathological data and treatment modalities for pancreatic vipomas: a systematic review.
Schizas D; Mastoraki A; Bagias G; Patras R; Moris D; Lazaridis II; Arkadopoulos N; Felekouras E
J BUON; 2019; 24(2):415-423. PubMed ID: 31127985
[TBL] [Abstract][Full Text] [Related]
56. Peptide histidine valine (PHV) is present and biologically active in the human female genital tract.
Palle C; Ottesen B; Fahrenkrug J
Regul Pept; 1992 Mar; 38(2):101-9. PubMed ID: 1574604
[TBL] [Abstract][Full Text] [Related]
57. [Basic study of peptide histidine isoleucine (PHI) immunoreactivity in the rat respiratory tract].
Ishizuka T; Kurosawa M
Arerugi; 1990 Jul; 39(7):577-86. PubMed ID: 2073138
[TBL] [Abstract][Full Text] [Related]
58. Watery diarrhea syndrome caused by multihormonal malignant pancreatic islet cell tumor secreting somatostatin, vasoactive intestinal peptide, serotonin, and prostaglandin E--a clinicopathological, biochemical, immunohistochemical, and ultrastructural study.
Chen YF; Liu TH; Chen SP; Pan GZ; Lu XH; Lu GJ; Zhong SX; Cai LX; Cui QC; Ran QY
Pancreas; 1986; 1(1):80-9. PubMed ID: 2883647
[TBL] [Abstract][Full Text] [Related]
59. Immunochemical study on PHI/PHM with use of synthetic peptides.
Yanaihara N; Yanaihara C; Nokihara K; Iguchi K; Fukata S; Tanaka M; Yamamoto Y; Mochizuki T
Peptides; 1984; 5(2):247-54. PubMed ID: 6548021
[TBL] [Abstract][Full Text] [Related]
60. [Mechanism of diarrhea and WDHA syndrome].
Ozawa Y; Shishiba Y
Nihon Rinsho; 1982; 40(5):1151-7. PubMed ID: 6288980
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
